ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Austin, TX, USA:

A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (COVID-19)

vaccine (SARS-CoV-2 rS) adjuvanted with Matrix-M™ in previously mRNA COVID-19 vaccinated adult participants ≥18 years of age and ba-...

Active, not recruiting
COVID-19
Biological: XBB.1.5 Vaccine (single dose)
Biological: XBB.1.5 Vaccine (Booster)

Phase 2, Phase 3

Novavax
Novavax

Austin, Texas, United States and 29 other locations

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Austin, Texas, United States and 217 other locations

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...

Active, not recruiting
COVID-19
Drug: PBI-0451 (Pomotrelvir)
Drug: Placebo

Phase 2

Pardes Biosciences

Austin, Texas, United States of America and 53 other locations

Tolerability and Efficacy of RJX in Patients With COVID-19

randomized, placebo controlled, multicenter Phase 1/2 study to evaluate the safety, tolerability and efficacy of RJX in patients with COVID-....

Active, not recruiting
COVID-19
Acute Respiratory Distress Syndrome
Drug: Placebo Comparator
Drug: Rejuveinix (RJX) Active Comparator

Phase 1, Phase 2

Reven Pharmaceuticals

New Braunfels, Texas, United States and 2 other locations

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 214 other locations

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: ritonavir
Drug: nirmatrelvir

Phase 1

Pfizer
Pfizer

Austin, Texas, United States and 32 other locations

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

The purpose of this study is to evaluate the safety, reactogenicity and immune responses of the severe acute respiratory syndrome coronavirus 2 (SARS...

Active, not recruiting
COVID-19
Biological: mRNA-CR-04 vaccine 3μg
Biological: mRNA-CR-04 vaccine 10μg

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Austin, Texas, United States and 3 other locations

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Enrolling
COVID-19
Influenza
Biological: Influenza and COVID-19 Combination B
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

Austin, Texas, United States and 158 other locations

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

The purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent D614)(primary series)& SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent B.1.351)(booster dose)>=4 months after last vaccination

Phase 3

Sanofi
Sanofi

Austin, Texas, United States and 93 other locations

Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines (COVID-19)

This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...

Active, not recruiting
COVID-19
Biological: NVX-CoV2601 (5μg)
Biological: NVX-CoV2601 (35μg)

Phase 2, Phase 3

Novavax
Novavax

Austin, Texas, United States of America and 49 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems